Ann Pediatr Endocrinol Metab.  2014 Mar;19(1):27-31. 10.6065/apem.2014.19.1.27.

Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty

• Baek JW
• Nam HK
• Jin D
• Oh YJ
• Rhie YJ
• Lee KH

• KMID: 1702660
• DOI: http://doi.org/10.6065/apem.2014.19.1.27

Abstract

PURPOSE
Gonadotropin-releasing hormone agonist (GnRHa) is known for improving final adult height in patients with central precocious puberty (CPP). This study aimed to investigate the age of menarche and near adult height in girls with CPP who had been treated with GnRHa.
METHODS
In this retrospective study, we reviewed the medical records of 71 Korean girls with CPP who had started menarche or reached over 13 years of bone age after long-term GnRHa treatment. We estimated near adult height using the Bayley-Pinneau method and identified the age of menarche in girls with CPP.
RESULTS
Mean chronological and bone age at menarche were 11.9+/-0.7 and 12.8+/-0.4 years, respectively. The period between menarche and the end of treatment was 14.0+/-5.6 months. Posttreatment near adult height was 163.8+/-4.7 cm, which was significantly greater than pretreatment predicted adult height (158.7+/-4.1 cm).
CONCLUSION
GnRHa treatment in girls with CPP could improve final adult height and made the age of menarche close to that of the general population.

Keyword

Gonadotropin-releasing hormone; Precocious puberty; Central; Menarche

MeSH Terms

Adult*
Female
Gonadotropin-Releasing Hormone*
Humans
Medical Records
Menarche*
Puberty, Precocious*
Retrospective Studies
Gonadotropin-Releasing Hormone

Reference

1. Carel JC, Leger J. Clinical practice: precocious puberty. N Engl J Med. 2008; 358:2366–2377. PMID: 18509122.

2. Shankar RR, Pescovitz OH. Precocious puberty. Adv Endocrinol Metab. 1995; 6:55–89. PMID: 7671102.

3. Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr. 1998; 157:363–367. PMID: 9625331.

4. Nam HK, Shin JY, Oh YJ, Rhie YJ, Yoo Y, Park SH, et al. The comparison of clinical factors according to growth velocity during gonadotropin-releasing hormone agonist treatment in central precocious puberty girls. Endocrinol Metab. 2010; 25:206–212.

5. Shin JH, Hu WK, Hwang IT, Yang S. Prediction of 1 year growth in girls with precocious puberty with GnRH agonist treatment by measurement of growth velocity at 3 months after treatment. J Korean Soc Pediatr Endocrinol. 2011; 16:80–85.

6. Lee PA, Neely EK, Fuqua J, Yang D, Larsen LM, Mattia-Goldberg C, et al. Efficacy of leuprolide acetate 1-month depot for central precocious puberty (CPP): growth outcomes during a prospective, longitudinal study. Int J Pediatr Endocrinol. 2011; 2011:7. PMID: 21860633.

7. Poomthavorn P, Suphasit R, Mahachoklertwattana P. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment. Gynecol Endocrinol. 2011; 27:524–528. PMID: 21501002.

8. Paul D, Conte FA, Grumbach MM, Kaplan SL. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab. 1995; 80:546–551. PMID: 7852518.

9. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952; 40:423–441. PMID: 14918032.

10. Ahn JH, Lim SW, Song BS, Seo J, Lee JA, Kim DH, et al. Age at menarche in the Korean female: secular trends and relationship to adulthood body mass index. Ann Pediatr Endocrinol Metab. 2013; 18:60–64. PMID: 24904853.

11. Cho GJ, Park HT, Shin JH, Hur JY, Kim YT, Kim SH, et al. Age at menarche in a Korean population: secular trends and influencing factors. Eur J Pediatr. 2010; 169:89–94. PMID: 19504269.

12. Neely EK, Lee PA, Bloch CA, Larsen L, Yang D, Mattia-Goldberg C, et al. Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery. Int J Pediatr Endocrinol. 2010; 2010:398639. PMID: 21437000.

13. Neely EK, Hintz RL, Parker B, Bachrach LK, Cohen P, Olney R, et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr. 1992; 121:634–640. PMID: 1403402.

14. Mul D, de Muinck Keizer-Schrama SM, Oostdijk W, Drop SL. Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty. Horm Res. 1999; 51:270–276. PMID: 10640887.

15. Carel JC, Lahlou N, Roger M, Chaussain JL. Precocious puberty and statural growth. Hum Reprod Update. 2004; 10:135–147. PMID: 15073143.

16. Kwon EB, Lee SJ, Cha M, Kim SY. Changes in the predicted adult height after gonadotropin-releasing hormone agonist treatment in girls with idiopathic true precocious puberty. Ann Pediatr Endocrinol Metab. 2012; 17:160–168.

17. Zachmann M, Sobradillo B, Frank M, Frisch H, Prader A. Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions. J Pediatr. 1978; 93:749–755. PMID: 712475.

18. Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr. 1995; 126:955–958. PMID: 7776106.

19. Unrath M, Thodberg HH, Schweizer R, Ranke MB, Binder G, Martin DD. Automation of bone age reading and a new prediction model improve adult height prediction in children with short stature. Horm Res Paediatr. 2012; 78:312–319. PMID: 23296315.

20. Lazar L, Padoa A, Phillip M. Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity. J Clin Endocrinol Metab. 2007; 92:3483–3489. PMID: 17579199.

21. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab. 2001; 86:4711–4716. PMID: 11600530.

22. Chae HW, Suh I, Kwon AR, Kim YJ, Kim YH, Kang DR, et al. Longitudinal standards for height and height velocity in Korean children and adolescents: the Kangwha study. [corrected]. J Korean Med Sci. 2013; 28:1512–1517. Erratum in: J Korean Med Sci 2013;28:1842. PMID: 24133358.